Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, Kanatsuka H, Shirato K
First Department of Internal Medicine, Tohoku University, School of Medicine, Sendai, Japan.
J Cardiovasc Pharmacol. 1995 Oct;26(4):541-7. doi: 10.1097/00005344-199510000-00006.
We aimed to clarify the size dependency of nicorandil-induced dilation in coronary microcirculation and the involvement of adenosine triphosphate (ATP)-sensitive potassium channels. Coronary arterial microvessels were observed through a microscope equipped with a floating objective in anesthetized open-chest dogs (n = 29). Heart rate and mean aortic pressure were maintained at control level. In 16 dogs, nicorandil was infused into the coronary in a cumulative fashion (0.1, 1.0, 10, and 100 micrograms/kg/min, for 5 min for each dose). In 13 dogs, glibenclamide (10 microM) was topically applied onto the observed area, and nicorandil was similarly infused. Nicorandil dilated vessels < 100 microns in diameter at all applied doses in a dose-dependent manner. Glibenclamide abolished the dilation of these vessels at the lower two doses. Vessels > 100 microns in diameter dilated only at the two higher doses and the dilation was not affected by glibenclamide. These data suggest that the vessels < 100 microns are more sensitive to this agent than other size vessels, and that ATP-sensitive potassium channels are involved in the nicorandil-induced dilation of vessels smaller than 100 microns, whereas the dilation of other size vessels occurs independently of this channel.
我们旨在阐明尼可地尔诱导的冠状动脉微循环扩张的大小依赖性以及三磷酸腺苷(ATP)敏感性钾通道的参与情况。通过配备浮动物镜的显微镜在麻醉开胸犬(n = 29)中观察冠状动脉微血管。心率和平均主动脉压维持在对照水平。在16只犬中,以累积方式(0.1、1.0、10和100微克/千克/分钟,每个剂量持续5分钟)向冠状动脉内输注尼可地尔。在13只犬中,将格列本脲(10微摩尔)局部应用于观察区域,并以类似方式输注尼可地尔。在所有应用剂量下,尼可地尔均以剂量依赖性方式使直径<100微米的血管扩张。格列本脲在较低的两个剂量下消除了这些血管的扩张。直径>100微米的血管仅在较高的两个剂量下扩张,且这种扩张不受格列本脲的影响。这些数据表明,直径<100微米的血管比其他大小的血管对该药物更敏感,并且ATP敏感性钾通道参与了尼可地尔诱导的直径小于100微米血管的扩张,而其他大小血管的扩张则独立于该通道发生。